This is a randomized, double-blind, active control, 8-week, flexible dose study of sertraline
vs. venlafaxine Extended Release in the acute treatment of Major Depression in male and
female outpatient sites that will recruit 15-20 patients each. Subjects will be randomized in
a 1:1 ratio to receive either sertraline or venlafaxine XR based on a computer-generated
randomized list.
Phase:
Phase 3
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center